(PDF) Efficacy and Safety of Lampalizumab for Geographic

Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration

JAMA Ophthalmology - United States

doi 10.1001/jamaophthalmol.2018.1544

Full Text

Abstract

Available in full text

Categories

Date

June 1, 2018

Authors

Srinivas R. Sadda

Christopher Brittain

Daniela Ferrara

Jason S. Ehrlich

Neil M. Bressler

Publisher

American Medical Association (AMA)

Related search

Clinical Endpoints for the Study of Geographic Atrophy Secondary to Age-Related Macular Degeneration

English

Macular Atrophy in Neovascular Age Related Macular Degeneration

Journal of Clinical Review & Case Reports

English

Visual Cycle Modulators Versus Placebo or Observation for the Prevention and Treatment of Geographic Atrophy Due to Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews

English

Choriocapillaris Changes in Dry Age-Related Macular Degeneration and Geographic Atrophy: A Review

English

In Vivo Imaging of Foveal Sparing in Geographic Atrophy Secondary to Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science

Molecular Neuroscience

Sensory Systems

English

Predictive Value of Fundus Autofluorescence for Development of Geographic Atrophy in Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science

Molecular Neuroscience

Sensory Systems

English

The Association of Geographic Atrophy and Decreased Renal Function in Patients With Age-Related Macular Degeneration

Sensory Systems

English

Progression of Geographic Atrophy in Age-Related Macular Degeneration Imaged With Spectral Domain Optical Coherence Tomography

English

Targeting Factor D of the Alternative Complement Pathway Reduces Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration

Science Translational Medicine

English